Weiyue Lu
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Glycosylation and Glycoproteins Research 3
- RNA Interference and Gene Delivery 2
-
- Nanoparticle-Based Drug Delivery 4
- Co-authors
- Hong Pan (3 shared papers)Xinzhe Yu (1 shared paper)Hang He (1 shared paper)Cao Xie (2 shared papers)Chen Jin (1 shared paper)Chao Xie (1 shared paper)Xinming Pu (1 shared paper)Deliang Fu (1 shared paper)
- Journals
- Biochemical Pharmacology (1 paper)Advanced Drug Delivery Reviews (1 paper)European Journal of Radiology (1 paper)Journal of drug targeting (1 paper)Oncotarget (1 paper)
- Partner nations
- ChinaSouth KoreaUnited States
In The Last Decade
Weiyue Lu
16 papers receiving 325 citations
Peers
Comparison fields: 5 of 66
- Biomaterials 111
- Pharmaceutical Science 21
- Hepatology 15
- Molecular Biology 135
- Oncology 46
Countries citing papers authored by Weiyue Lu
This map shows the geographic impact of Weiyue Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyue Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyue Lu more than expected).
Fields of papers citing papers by Weiyue Lu
This network shows the impact of papers produced by Weiyue Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyue Lu. The network helps show where Weiyue Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiyue Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 69 | |
| 2 | 2015 | 64 | |
| 3 | 2008 | 40 | |
| 4 | 2013 | 38 | |
| 5 | 2007 | 24 | |
| 6 | 2009 | 22 | |
| 7 | 2014 | 19 | |
| 8 | 2019 | 17 | |
| 9 | 2010 | 15 | |
| 10 | Preparation and in vitro targeting of sterically stabilized liposomes modified with chimeric TNT-3 monoclonal antibody. | 2006 | 4 |
| 11 | [Poly(arginine)8 enhanced intestinal absorption of insulin-loaded nanoparticles]. | 2012 | 4 |
| 12 | 2017 | 4 | |
| 13 | [Diffusion behaviors of drugs in thermosensitive in situ gels]. | 2004 | 3 |
| 14 | 2017 | 2 | |
| 15 | [Antifibrotic effects of cyclic RGD-peptide mediated liposomal interferon: an experimental on rats]. | 2005 | 2 |
| 16 | 1997 | 1 |
About Weiyue Lu
Weiyue Lu is a scholar working on Molecular Biology, Biomaterials, Pharmaceutical Science, Hepatology and Surgery, having authored 16 papers that have together received 328 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (4 papers), Glycosylation and Glycoproteins Research (3 papers), Liver physiology and pathology (2 papers), RNA Interference and Gene Delivery (2 papers), Advanced Drug Delivery Systems (2 papers), Sympathectomy and Hyperhidrosis Treatments (1 paper), Lymphatic Disorders and Treatments (1 paper) and Microplastics and Plastic Pollution (1 paper). The work is most often cited by research in Biomaterials (111 citations), Pharmaceutical Science (21 citations), Hepatology (15 citations), Molecular Biology (135 citations) and Oncology (46 citations). Weiyue Lu has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Hong Pan, Xinzhe Yu, Hang He, Cao Xie, Chen Jin, Chao Xie, Xinming Pu, Deliang Fu, Di Yang and Gang Wei. Their work appears in journals such as Biochemical Pharmacology, Advanced Drug Delivery Reviews, European Journal of Radiology, Journal of drug targeting and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.